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Abstract
Objective—Agricultural pesticide handlers are at an elevated risk for overexposure to 
organophosphate (OP) pesticides, but symptoms can be difficult to recognize, making biomarkers 
invaluable for diagnosis. Occupational monitoring programs for cholinesterase depression 
generally rely on measuring activity of either of two common blood cholinesterases which serve 
as proxy measurements for nervous-system acetylcholinesterase activity: red blood cell 
acetylcholinesterase (AChE) and plasma butyrylcholinesterase (BChE). These biomarkers, 
however, may be affected differentially by some OPs and the relationship between them has not 
been well characterized. We aim to determine the association between blood acetylcholinesterase 
(AChE) and butyrylcholinesterase (BChE) activity levels and assess whether they produce 
comparable classifications of clinical cholinesterase depression among organophosphate pesticide 
handlers.
Methods—Using blood samples from 215 participants of the Washington State Cholinesterase 
Monitoring Program, we quantified changes in AChE and BChE activity from before and after 
exposure to OP pesticides and calculated Pearson correlation statistics for correlation of AChE and 
BChE changes in activity, as well as weighted Kappa statistics for agreement of classification of 
clinical cholinesterase depression based on AChE versus BChE measurements.
Results—AChE and BChE activity measurements are weakly negatively correlated in our study 
population. Reaching a clinical threshold for diagnosis of cholinesterase depression based on the 
AChE marker did not correlate with reaching clinical depression based on the BChE marker.
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Conclusions—Both AChE and BChE should be measured in monitoring programs because they 
may both give potentially important but disparate classifications of clinical cholinesterase 
depression.
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INTRODUCTION
Organophosphates (OPs) are among the most widely used pesticides in the United States. 
OPs act by inhibiting acetylcholinesterase (AChE), an enzyme that is essential for the proper 
functioning of the nervous system[1] as it hydrolyzes the neurotransmitter acetylcholine in 
the nerve synapse.[2] Upon irreversible inhibition by an OP, AChE can no longer bind 
acetylcholine to terminate synaptic transmission. Inhibition of AChE in humans can cause 
many acute symptoms including dizziness, nausea, difficulty breathing and even death. The 
presence and severity of these symptoms depend in part on the degree of AChE depression, 
though symptoms are not always present in AChE-depressed individuals.
Occupational OP pesticide handlers are at an elevated risk for OP intoxication due to the 
potential for high exposure to these chemicals through skin contact, inhalation or accidental 
ingestion. Mixing or applying these pesticides can result in potentially harmful levels of 
exposure through one or more high exposure events or through chronic lower-level 
exposure.[3] Because of this risk, California and Washington have instituted longitudinal 
cholinesterase monitoring programs for OP handlers in order to identify and treat instances 
of OP intoxication early on.[4,5]
Outward symptoms of OP intoxication can be difficult to recognize, so it is important to 
have a way of quantifying an individual’s cholinesterase depression through objective 
measurement. In order to determine whether a case of OP intoxication has occurred, a 
measurement of relative change in cholinesterase activity is obtained by comparing a 
baseline, pre-exposure cholinesterase activity measurement with another measurement taken 
after the individual has been OP-exposed. A baseline measurement is necessary for 
comparison to the exposed measurement due to the substantial variability in baseline 
cholinesterase levels in the general population. From this relative measure it is determined if 
an individual has crossed a threshold into clinical cholinesterase depression, often defined as 
a 20% decrease in activity from baseline, requiring behavioral or medical intervention. 
Recently developed methods allow assessment of an individual’s degree of cholinesterase 
inhibition without baseline biomarker measurement,[6] but use of a baseline measurement 
remains much more common.
There are two biomarkers that are commonly used to determine the extent of an individual’s 
cholinesterase depression.[7] AChE activity from whole blood erythrocytes can be measured 
as a proxy for the cholinergic AChE that is found in the nervous system, as can 
butyrylcholinesterase (BChE), which is measured in plasma. Both blood AChE and BChE 
inhibition are used as proxy measurements for cholinergic AChE inhibition.
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In epidemiologic research on cholinesterase depression, BChE is the more commonly used 
biomarker even though this form of cholinesterase is not known to be directly involved in 
neuronal cholinergic processes. One reason for this may be that studies of the reliability of 
these biomarkers have found that assays for BChE tend to produce measurements that have 
greater correlation within and between laboratories, compared to measurement of AChE, 
meaning the BChE measurement has greater reproducibility.[8–10] For example, in the 
Washington State Cholinesterase Monitoring program, within-laboratory coefficients of 
variation were around 2.5% for BChE measurements but were 16.7% for AChE 
measurements.[7] Since the goal of measuring cholinesterase in blood is to obtain a proxy 
measurement of cholinergic AChE activity in the central nervous system, which cannot be 
readily measured, questions remain as to whether red blood cell AChE or plasma BChE is 
the more appropriate marker and under what conditions.[11]
There is evidence supporting and against use of either biomarker. AChE measurement, 
although it has somewhat poorer reproducibility of measurements, is considered by some to 
be a more appropriate proxy for cholinergic AChE than is BChE due to the biological 
similarity of the enzymes.[11] Though BChE is more reliably measurable due to lower 
variability of the assay, the relevance of this enzyme as a proxy for cholinergic AChE is still 
debated;[11] BChE has been shown to be a significant predictor of symptoms of OP 
poisoning, but does not show a strong dose-response relationship[12] and is not inhibited by 
all OPs in the same way as AChE.[13] For these reasons, in the literature to date it is still 
unclear which biomarker is most appropriate for assessing OP intoxication.
In this study we have evaluated the relationship between AChE and BChE as biomarkers for 
cholinesterase depression from OP pesticides, and assessed whether these measures can be 
used interchangeably to diagnose cases of OP intoxication. The participants from whom the 
data were generated are organophosphate pesticide handlers in Washington State 
participating in the statewide cholinesterase monitoring program.
METHODS
Data collection
Enrollment—The Washington State Cholinesterase Monitoring Program was designed to 
actively monitor, record, manage and attempt to prevent occupational overexposures to 
cholinesterase inhibitors.[4] This program is overseen and enforced by the Washington State 
Department of Labor and Industries and requires employers to offer cholinesterase activity 
level monitoring to agricultural pesticide applicators working in the state who meet certain 
temporal and chemical exposure criteria.[14] As part of this program, OP handlers are 
invited to be seen at a clinic before and during the pesticide application season in order to 
undergo cholinesterase monitoring. Participants in the present study were recruited from the 
participants in the Washington State cholinesterase program, which is by law made available 
to employees who handle class I and II organophosphate pesticides for at least 30 hours 
within a 30 day period during the pesticide application season[15]. Participation in the 
cholinesterase monitoring program is not mandatory - employees have the choice whether or 
not to participate in the program. Therefore, in order to participate in the present study, the 
individual must have already chosen to participate in cholinesterase monitoring.
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Participants for this study were recruited at three clinics of the cholinesterase monitoring 
program between 2006 and 2011. Recruitment occurred at the time of a follow-up visit to 
the clinic during the pesticide spray season, and at that time consenting participants 
completed a self-administered computer-based survey in either English or Spanish to 
provide information on demographics, pesticide use, workplace practices including use of 
personal protective equipment and other details related to job duties and workplace pesticide 
exposure.[16] For two of the three clinics, enrollment occurred when the participant came 
for their blood draw. The third clinic travelled to worksites to provide cholinesterase 
monitoring on-site, and study personnel travelled with them to invite all participating 
pesticide handlers to join the study.
Cholinesterase measurements—Blood samples for this analysis were collected as part 
of the WA Cholinesterase Monitoring Program. One baseline blood sample was collected 
from each participant during their pre-season visit to the clinic, with BChE and AChE 
measurements made from the same blood sample. This captures each participants “normal” 
BChE and AChE activity levels, i.e., at a time when they report not having been recently 
exposed to cholinesterase inhibiting pesticides. An additional sample was collected during 
the pesticide application season (April-July) at one or more follow-up visits.[17] This 
sample was intended to capture BChE and AChE activity at a time when the participant was 
likely to have been exposed, and possibly overexposed, to OPs.
Laboratory analysis of blood samples for BChE and AChE activity were conducted by the 
Washington State Public Health Laboratories (2006) and Pathology Associates Medical 
Laboratories from 2007–2011. Both laboratories used the Ellman colorimetric enzymatic 
assay to measure BChE and AChE activity.[18]
Subject and sample selection—Our analysis includes a total of 215 individuals who 
completed one baseline visit to the clinic and at least one follow-up visit during the pesticide 
spray season in any of the data collection years. One measurement per person of AChE 
activity proportion change from baseline and BChE activity proportion change from baseline 
are included in the following analyses. Some participants had multiple follow-up visits 
during the study period, but for the purposes of the present analysis, we included only one 
visit per person, selecting the visit with the maximum BChE depression for that individual. 
We included the observation for each individual that reflected the greatest decrease in BChE 
activity level in order to capture the maximum depression observed for each participant over 
the study period. We used BChE measurement for determination of maximum 
cholinesterase depression because measured BChE activity is generally more sensitive to OP 
inhibition than is AChE activity.[19] A total of 61% of participants reported handling 
pesticides within one week prior to their clinic visit, including 19% who reported handling 
organophosphates within the past day.
Statistical Analyses
The goal of the statistical analyses was to examine the nature of the relationship between 
AChE and BChE measurements, with a particular focus on standard cutoffs used to indicate 
cholinesterase depression. Correlation coefficients and p-values were obtained using PROC 
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CORR in SAS. Fisher’s transformation was used to calculate confidence intervals for the 
correlation coefficients. Sensitivity analyses were conducted to test whether our method of 
sample selection (i.e., sample showing maximum depression vs. a random sample) affected 
the results. All analyses were performed using SAS version 9.3.
Quantifying Cholinesterase Inhibition—Our outcomes were calculated as proportion 
decreases in cholinesterase enzyme activity between measurements taken at baseline and 
follow-up visits. It is necessary to measure cholinesterase depression as a relative change in 
enzyme activity between baseline and follow-up because of the substantial population 
variability in baseline BChE and AChE activity levels.
We used least squares regression to examine change in AChE activity level as a predictor of 
change in BChE activity level across strata of OP pesticide exposure and other factors. To 
estimate the effects of individual pesticides on the relationship between AChE and BChE 
proportion change while controlling for individual pesticide use, we constructed linear 
regression models adjusted for each pesticide used, representing the rarer pesticides (i.e., 
those used by fewer than 20 participants: phosmet, diazinon, malathion, methidathion, 
methamidophos) with a single indicator variable for whether a participant reported use of 
any of the rare pesticides.
Though the degree of neurological effect of ChE depression appears to vary between 
individuals, 15% depression is considered to reflect OP overexposure[20], while 40–50% 
depression is associated with mild neurotoxicity and more serious effects are anticipated 
after depression reaches 80%[21]. In the literature, cutoffs in percent depression that are 
used for diagnosing cholinesterase depression vary, but are typically between 20% and 30% 
decreases in activity for AChE and BChE.[2,17,20,22] We used these cutoffs in the analysis 
to assess agreement of diagnosis of cholinesterase depression when using either biomarker.
Assessing Agreement between Biomarker Measurements—In order to 
characterize the agreement of ChE proportion change measurements, distributions of AChE 
proportion change and BChE proportion change were categorized into tertiles which were 
examined for concordance using the weighted Kappa statistic.
The Kappa coefficient (K) tests agreement of paired measures. The value of the Kappa 
statistic takes into account the agreement between the variables that could be due to chance 
by subtracting out the proportion of concordant results that would be expected to occur by 
chance alone.[23] A Kappa of 1 indicates perfect agreement between the measures, while a 
negative Kappa indicates that there is less agreement than would be expected by chance 
alone. Generally a Kappa value of 0.80 is considered to indicate good concordance between 
the measures, and 0.67<K<0.80 indicates moderate concordance.[23]
Based on common guidelines for diagnosing ChE depression using these biomarkers, the 
cohort was also categorized into those who had at least 20% BChE depression between 
baseline and follow-up and those who did not, and separately stratified into those who had 
20% AChE depression between baseline and follow-up and those who did not. We then 
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performed Kappa tests to assess agreement of classification into category of “ChE 
Depressed” or “Not ChE Depressed” based on measurement by either biomarker.
Pesticide Exposure Score Algorithm—To quantify each participant’s cumulative 
recent OP pesticide exposure, we employed an exposure algorithm developed for the 
Agricultural Health Study.[19] Based on this method, we created a z-score that quantified 
relative total exposure to cholinesterase-inhibiting pesticides in the 30 days prior to the 
participant’s clinic visit. The algorithm used the exposure information from the participant 
survey, incorporating self-reported use of individual pesticide, total hours of pesticide use, 
whether the participant mixed and/or applied pesticides, consistency of use and types of 
personal protective equipment (e.g., gloves), methods of application (e.g., backpack sprayer, 
tractor, as well as use of an enclosed cab), personal hygiene (time between pesticide mixing/
application and washing, usual time until changing clothes after a spill), and other factors 
influencing exposure. Each factor was weighted based on published industrial hygiene 
literature and on pilot study data from the Agricultural Health Study.
Sensitivity Analysis—To test whether selection of the follow-up visit with the most 
extreme decrease in BChE activity per participant affected the observed correlations 
between AChE and BChE, we performed a sensitivity analysis. For this analysis we repeated 
all tests for correlation after calculating AChE and BChE proportion changes using the first 
follow-up observation for each participant rather than the follow-up observation with the 
most extreme percent decrease in BChE activity.
RESULTS
Descriptive Statistics
215 individuals with one baseline and at least one follow-up observation each were included 
in the analyses. Study participants were almost entirely Latino males younger than age 50, 
with more than half of the study population under age 35 (Table 1). The majority had 
completed education through only middle school and most were not able to read in English. 
Most participants completed the self-administered computer survey in Spanish (data not 
shown).
At their follow-up visit, participants reported the type of pesticides they handled or applied 
in the prior 30 days (Supplementary Table 1). The OP chlorpyrifos was overall the most 
commonly reported pesticide in this cohort, reportedly used by over half of all participants. 
The carbamate pesticide carbaryl was the second most commonly reported pesticide, 
reported by over one quarter of participants. Other pesticides were used by only a minority 
of the cohort, with no other pesticide reported by more than 13.5% of participants.
Though some participants reported using multiple pesticides in the 30 days prior to their 
visit, the majority of participants reported only one (Supplementary Table 2), chlorpyrifos 
being the most common among single pesticide users (data not shown). Few participants 
reported using more than 2 pesticides during the 30 days prior to their follow-up clinic visit. 
Among those who reported using multiple pesticides, the most common combination was 
carbaryl with chlorpyrifos (n=17), followed by carbaryl with azinphos methyl (n=7), or 
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malathion with azinphos methyl (n=7). No more than 6 participants used any other given 
combinations of pesticides. We did not perform separate analyses for participants who used 
multiple pesticides because of these small numbers.
Measurements of BChE proportion change were approximately normally distributed with a 
median value of −0.05, a mean value of −0.06, with a standard deviation of 0.10, and a 
range of −0.39 to 0.19. Measurements of AChE proportion change were also normally 
distributed but were more varied, with a median value of −0.01, a mean value of 0.00 and a 
standard deviation of 0.14, and a range of −0.50 to 0.76.
As shown in Table 2, standard deviations tended to be slightly larger for the AChE 
measurements. This table also shows mean proportion change for both AChE and BCHE 
among subjects with ≥10%, ≥15%, or ≥20% decrease from baseline in either one. 
Participants who had at least 10%, 15% or 20% decrease in activity of one biomarker did not 
tend to show a similar amount of decrease in activity of the other biomarker. For those with 
at least 20% decrease in BChE activity, their AChE activity slightly increased from baseline, 
on average, by 5%. Among participants in the top tertile for pesticide exposure score, there 
was a negative average change for BChE but a positive average change for AChE. We only 
had 5 participants with at least 30% BChE depression, and just 4 participants with at least 
30% AChE depression.
Cholinesterase depression in our study sample is similar to that of the full population of the 
Washington State Cholinesterase Monitoring Program participants (Supplementary Table 3). 
Overall the percentages of individuals with at least 20% cholinesterase depression in each 
year were similar between participants in our study and the state cholinesterase monitoring 
program.[24] Although the percentage of workers with at least 20% depression is somewhat 
higher among subjects in the present study in some years of data collection, the numbers of 
subjects in these subgroups tend to be small.
Correlation between proportion changes of AChE and BChE
AChE and BChE proportion change are weakly negatively correlated, with correlation 
coefficient −0.14 (95% CI −0.27, −0.01) (Figure 1). When restricting the analysis to 
individuals who had 10% or 15% AChE or BChE activity depression, the two biomarkers 
remained weakly negatively correlated (Table 3). The same trend persisted when restricting 
to participants who had applied OP pesticides within the past week or who had used only 
chlorpyrifos within the past 30 days. We were unable to restrict to sole users of other 
pesticides due to small numbers of participants using other pesticides. Correlation 
coefficients are not shown for AChE or BChE depression of ≥20% due to small numbers.
Kappa Statistic
We observed little concordance between AChE and BChE activity when categorized either 
by tertile of enzyme activity change or as above or below the clinical threshold for 
cholinesterase depression (Table 4). The kappa coefficients indicated a weak negative 
association between measured AChE and BChE activity levels.
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For a sensitivity analysis, z-transformed correlation coefficients and corresponding 95% 
confidence intervals based on AChE and BChE proportion change measurements from the 
first follow-up visit of each participant were calculated (Supplementary Table 4). This is 
compared to data in Table 3, which shows z-transformed correlation coefficients for AChE 
and BChE proportion change when sampling the follow-up visit with the greatest decrease 
in BChE activity from baseline.
All correlation coefficients that are presented in Table 3 are captured within the 95% 
confidence limits of the correlation coefficients obtained using the alternative sampling 
method, i.e., using the first follow-up measurement rather than the one showing the greatest 
change in BChE from baseline. The correlation results obtained using either method are not 
statistically significantly different.
A Kappa statistic was also calculated to quantify concordance of tertile assignment using the 
alternative sampling method. The weighted Kappa was −0.07 (95%CI −0.18 to 0.03). This 
was similar to the value calculated using the participant samples with the greatest proportion 
change and were within the confidence limits of the Kappa value reported for tertile 
agreement in Table 4, demonstrating that the sampling method does not significantly affect 
the estimated concordance.
DISCUSSION
The present study found a weak negative correlation between BChE and AChE 
measurements of cholinesterase depression among pesticide handlers. Amount of recent 
exposure to cholinesterase inhibiting insecticides did not have an appreciable effect on the 
observed correlations. These data suggest that diagnosis of cholinesterase depression in this 
population is contingent upon which biomarker, AChE or BChE, is used for diagnostic 
testing.
Blood BChE and AChE activity levels have both been used as surrogate biomarkers for 
cholinergic AChE depression in screening programs as well as in epidemiologic studies. 
However, we were unable to identify any published research on the comparability of these 
two biomarkers, particularly in regard to differences in their identification of clinically-
relevant cholinesterase depression of 20% or greater.
Our results show a weak negative correlation between measurement of AChE and BChE 
proportion change. This relationship persisted after restricting to those with relatively high 
exposure to OP insecticides, those who used chlorpyrifos only, and those who had been 
classified as cholinesterase depressed based on current guidelines.
The weighted Kappa coefficients for agreement between categories of cholinesterase 
depression based on the two biomarkers also showed a weak negative association. Since 
individuals who reach at least 20% BChE depression are not likely to also have at least 20% 
AChE depression, and vice versa, these biomarkers cannot be used interchangeably for 
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diagnostic purposes. Furthermore, sensitivity analyses showed that the observed results are 
robust to our sampling method.
Our correlation results were additionally robust to the method of selecting data samples. 
Sensitivity analyses indicated that selecting follow-up observations for each individual that 
reflected the greatest decrease in BChE activity for that individual produced generally 
similar correlation coefficients between AChE and BChE as selecting the first follow-up 
observation. There are important factors to consider when interpreting the results of this 
study. Over the course of the WA cholinesterase monitoring program, the number of events 
of cholinesterase depression among participants has decreased.[25] This may be a result of 
the effectiveness of the cholinesterase monitoring program in reducing incidence of over-
exposure to OP insecticides, or may be due to the fact that OP insecticide use in Washington 
State decreased between 2006 and 2011.[26] In addition, these markers of cholinesterase 
depression may not be sufficiently sensitive at low exposure levels,[6] though this is less of 
a concern for this relatively high-exposure population. It is possible, however, that this issue 
of sensitivity could be contributing to the differences observed between the two biomarkers.
This study has a number of strengths. It is large for a study of its kind, and has both baseline 
and follow-up blood samples from participants. We were able to quantify both AChE and 
BChE from a single blood draw so as to more appropriately compare the measures. The 
generalizability of our results is improved by the fact that the study cohort is similar to the 
statewide cholinesterase monitoring program participants with respect to cholinesterase 
depression as well as demographics.[17,27]
Certain limitations of this study must be considered. Due to the self-reported nature of our 
exposure data, misclassification of exposure is possible. However, a validation study of the 
survey instrument shows that problems with recall in this study are likely minimal and do 
not introduce a significant amount of bias.[16] Since we do not have complete data on which 
pesticides were used by our participants and exactly how much of each was used, we are 
unable to fully account for the differential effects of various OPs (e.g., chlorpyrifos) on 
BChE and AChE activity, although we accounted for this with the available data.
We are unaware of any other studies that have examined the relation between AChE and 
BChE activity measurements in a human population. Our analyses suggest little agreement 
between the two measures, at least at the exposure levels experienced by these farm 
workers, and that differences in patterns of these markers must be considered in interpreting 
results. More research is needed to determine the conditions under which AChE vs. BChE is 
the more appropriate biomarker. Our study lacked the necessary data to address this 
question. Thus, for the present, we recommend that both be measured in cholinesterase 
monitoring programs or for determining cholinesterase depression in other occupational 
settings.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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What this paper adds
• Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) activity in 
blood are commonly measured for assessing cholinesterase depression.
• Changes in AChE and BChE activity are only weakly correlated.
• Cholinesterase monitoring programs should measure both AChE and BChE, as 
the two biomarkers can give disparate but potentially important classifications 
of clinical cholinesterase depression.
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Correlation between AChE and BChE proportion change (N=215)
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Table 1
Characteristics of participants at enrollment
Characteristic n=215 %
Gender
 Male 213 99.07
 Missing 2 0.93
 Age category (years)
 18–24 36 16.74
 25–34 95 44.19
 35–49 68 31.63
 50+ 15 6.98
 Missing 1 0.47
Ethnicity
 Black 1 0.47
 White 1 0.47
 Latino 210 97.67
 Missing 3 1.40
Education completed
 None 8 3.72
 Partial Primary school 33 15.35
 Primary school 74 34.42
 Middle school 70 32.56
 High school 29 13.49
 Missing 1 0.47
Able to read English
 No 137 63.72
 Yes 76 35.35
 Missing 2 0.93
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Table 3
Correlation of AChE and BChE proportion change measurements
Subset of cohort N Correlation coefficients* 95% CI
Entire cohort 215 −0.14 −0.27, −0.01
≥10% BChE depression 70 −0.11 −0.33, 0.13
≥10% AChE depression 34 −0.24 −0.54, 0.10
≥15% BChE depression 39 −0.28 −0.55, 0.04
≥15% AChE depression 17 −0.19 −0.61, 0.32
Handled only chlorpyrifos 92 −0.15 −0.34, 0.06
Handled OP within past 7 days 132 −0.10 −0.27, 0.07
Handled only chlorpyrifos within past 7 days 59 −0.16 −0.40, 0.10
Top tertile of exposure score 56 −0.20 −0.44, 0.07
*
Presented Pearson correlation coefficients have been z-transformed, but are identical to the untransformed Pearson correlation coefficients to the 
tenths decimal place.
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Table 4
Concordance between AChE and BChE for different categorizations of cholinesterase depression (N=215)
Categories Kappa 95% CI
≥20% Depression by BChE and AChE −0.05 (−0.08, −0.02)
Tertile of BChE and AChE Depression* −0.11 (−0.21, −0.01)
*
Weighted Kappa coefficients are used to quantify tertile agreement
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